Fig. 1From: Joint modelling of multivariate longitudinal clinical laboratory safety outcomes, concomitant medication and clinical adverse events: application to artemisinin-based treatment during pregnancy clinical trialBox plots profiling clinical laboratory safety outcomes for antimalarial drugs over 63-day follow-up among pregnant women in MalawiBack to article page